1-es típusú cukorbetegség: vizsgálatok itt: Kína
40 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Where
- Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hangzhou, Harbin, Hohhot, Jinan, Lanzhou, Luoyang, Nanchang, Nanjing, Pingxiang, Shanghai, Shenyang, Shenzhen, Tianjin, Wuhan, Wuxi, Yueyang, Zhengzhou, Zhenjiang
- Életkor
- 1 év to 25 év
- People
- 723 worldwide
- Run by
- Sanofi
See details and how to joinNCT07088068 - 3. fázisNot yet taking people in KínaA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Beijing, Changchun, Chengdu, Guangzhou, Huzhou, Nanjing, Ningbo
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - 3. fázisNot yet taking people in KínaA Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
- Where
- Beijing, Bozhou, Cangzhou, Changzhou, Chongqing, Daqing, Ganzhou, Guangzhou, Jiaxing, Jinan, Liuzhou, Luoyang, Luzhou, Sanya, Shanghai, Shenyang, Shiyan, Suzhou, Wuhan, Xi'an, Xuancheng, Yuncheng, Zhengzhou
- Életkor
- 18 év and over
- People
- 330 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07922330 - 3. fázisNot yet taking people in KínaA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Beijing, Cangzhou, Changchun, Changsha, Chengdu, Danyang, Ganzhou, Guiyang, Hengshui, Huizhou, Lanzhou, Panjin, Qiqihar, Shanghai, Suzhou, Xiamen, Xianyang, Zigong
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - No phaseTaking peopleWashed Microbiota Transplantation for Type 1 Diabetes Mellitus
- Where
- Nanjing
- Életkor
- 3 év to 100 év
- People
- 50
- Run by
- The Second Hospital of Nanjing Medical University
See details and how to joinNCT06256614 - 2. fázisNot yet taking people in KínaJAK1 Inhibitor Ivarmacitinib for Improving Pancreatic Islet Function in T1D
- Where
- Shanghai
- Életkor
- 10 év to 40 év
- People
- 132
- Run by
- Huijie Zhang
See details and how to joinNCT07845955 - No phaseTaking peopleEnvironmental Determinants of Type 1 Diabetes Risk
- Where
- Changsha
- Életkor
- 3 év to 70 év
- People
- 11 240
- Run by
- Second Xiangya Hospital of Central South University
See details and how to joinNCT07835724 - No phaseTaking peopleEffect of Different Carbohydrate Intake Patterns on Glycemic Control in Patients With Type 1 Diabetes
- Where
- Nanjing
- Életkor
- 18 év to 70 év
- People
- 80
- Run by
- Yang Tao
See details and how to joinNCT06273631 - 1. fázisTaking peoplePhase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
- Where
- Kunming
- Életkor
- 18 év to 50 év
- People
- 36
- Run by
- Shanghai Minwei Biotechnology Co., Ltd
See details and how to joinNCT07803809 - 3. fázisNot yet taking people in KínaAMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Where
- Beijing, Cangzhou, Changchun, Changde, Changzhou, Chengdu, Chongqing, Hefei, Huzhou, Jilin City, Jinan, Kaifeng, Langfang, Luoyang, Nanjing, Nanyang, Panjin, Shanghai, Shenzhen, Shijiazhuang, Shiyan, Suzhou, Xining, Zhengzhou, Zhenjiang
- Életkor
- 45 év and over
- People
- 1778 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07797335 - Korai 1. fázisCsak meghívásosAn Exploratory Clinical Study Evaluating Allogeneic iPSC-derived Pancreatic Islet Cells (CRG-002) for the Treatment of Diabetic Patients With Hypoglycemia Unawareness or Severe Hypoglycemic Events
- Where
- Hefei
- Életkor
- 18 év to 70 év
- People
- 10
- Run by
- Celregen Therapeutics
See details and how to joinNCT07503028 - No phaseTaking peopleEvaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System
- Where
- Zibo
- Életkor
- 18 év and over
- People
- 36
- Run by
- SiBionics, Co, Ltd
See details and how to joinNCT07745244 - No phaseTaking peopleAI-Assisted Remote Insulin Pump Optimization in T1DM
- Where
- Nanjing
- Életkor
- 14 év to 65 év
- People
- 50
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07732777 - 2/3. fázisTaking peopleOpen-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes
- Where
- Nanjing
- Életkor
- 18 év to 65 év
- People
- 96
- Run by
- Nanjing Medical University
See details and how to joinNCT07548996 - No phaseTaking peopleGenetic Risk Score of Type 1 Diabetes Mellitus for Progression to Insulin in Diabetic Patients Lack of Predictive Value: a Multicenter Nested Case-control Study
- Where
- Changsha
- Életkor
- 14 év to 50 év
- People
- 2950
- Run by
- Second Xiangya Hospital of Central South University
See details and how to joinNCT07621445 - No phaseTaking peopleChina Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
- Where
- Changsha, Changzhi, Haikou, Hangzhou, Harbin, Kunming, Lanzhou, Luoyang, Nanjing, Shenzhen, Ürümqi
- People
- 20 000
- Run by
- Second Xiangya Hospital of Central South University
See details and how to joinNCT05498974 - Korai 1. fázisTaking peopleAllogeneic Anti-CD7 CAR-T for Type 1 Diabetes
- Where
- Shanghai
- Életkor
- 18 év to 40 év
- People
- 9
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07528105 - No phaseTaking peopleSequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM
- Where
- Shanghai
- Életkor
- Up to 18 év
- People
- 50
- Run by
- Children's Hospital of Fudan University
See details and how to joinNCT03835312 - No phaseTaking peopleIntervention for Children With Type 1 Diabetes Targeting Gut Microbes
- Where
- Shanghai
- Életkor
- 6 év to 12 év
- People
- 110
- Run by
- Children's Hospital of Fudan University
See details and how to joinNCT06198725 - No phaseTaking peopleEstablishment of Screening Pathway for High-Risk Population of Type 1 Diabetes
- Where
- Beijing
- Életkor
- 4 év and over
- People
- 340
- Run by
- Peking University First Hospital
See details and how to joinNCT07468474 - 3. fázisTaking peopleClinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus
- Where
- Nanjing
- Életkor
- 18 év to 65 év
- People
- 90
- Run by
- Nanjing Medical University
See details and how to joinNCT07258394 - 1. fázisTaking peopleMS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
- Where
- Changsha, Chengdu, Shanghai
- Életkor
- 18 év and over
- People
- 45
- Run by
- Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
See details and how to joinNCT04187443 - 1. fázisTaking peoplePhase I Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 1 Diabetes Mellitus
- Where
- Tianjin
- Életkor
- 18 év to 60 év
- People
- 10
- Run by
- Hangzhou Reprogenix Bioscience, Inc
See details and how to joinNCT06731218 - No phaseTaking peopleStudy on the Improvement of Metabolic Indicators in Type 1 Diabetes Patients
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 150
- Run by
- Peking University First Hospital
See details and how to joinNCT07144696 - No phaseTaking peopleEfficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2
- Where
- Beijing, Changsha, Chengdu, Hangzhou, Luoyang, Quanzhou, Shenyang, Shenzhen, Tangshan, Wuhan
- Életkor
- 6 év and over
- People
- 400
- Run by
- Second Xiangya Hospital of Central South University
See details and how to joinNCT07097818